<p>Mice were injected with various immunogens as shown on the x-axis; saline (○), unencapsulated OVA with saline (▪), CP (▴), CP-OVA (▴), CPZ (⧫), CPZ-OVA (⧫), liposome (•), or liposome-OVA (•). Splenocytes were harvested, stained and gated on lymphocytes as described in the methods section. The frequency of CD4 subpopulations are shown on the y-axis. (A) Total CD4+ cells, (B) CD4+ memory cells (CD4+CD44<sup>hi</sup>), (C) IFNγ-producing CD4+ cells, (D) IL-17 producing CD4+ cells and (E) IL-4 producing CD4 cells. The cell populations from immunized groups were compared using one-way ANOVA and Bonferroni’s post-hoc test). ***p<0.001, **p<0.01, *p<0.05. Representative of 2 independent experiments.</p
<p>(A–C) Mice were primed with Env-CN54 gp140 in combination with either alum alone or a medium (“me...
<div><p>The need for CD4+ T cell responses to arise <i>de novo</i> following vaccination can limit t...
<p>Lymphocytes from the spleens of naïve, Liporale™-BCG vaccinated (BCG oral) or subcutaneously vacc...
<p>Mice were injected with various immunogens as shown on the x-axis; saline (○), unencapsulated OVA...
BACKGROUND: Modifications of adjuvants that induce cell-mediated over antibody-mediated immunity is ...
BackgroundModifications of adjuvants that induce cell-mediated over antibody-mediated immunity is de...
<div><h3>Background</h3><p>Modifications of adjuvants that induce cell-mediated over antibody-mediat...
Modifications of adjuvants that induce cell-mediated over antibody-mediated immunity is desired for ...
<p>T cells (2×10<sup>5</sup> cells/mL) were co-cultured with DC (2×10<sup>4</sup> cells/mL) in the p...
<p>Antibody titers after vaccination schedule, composed of 3 weekly s.c. injections with control sal...
<p>B3Z cells (1×10<sup>5</sup> cells/200 uL/well) were co cultured with DC 2.4 (5×10<sup>4</sup> cel...
<p>(<b>A</b>) Relative representation of Th CD4<sup>+</sup>, Tc CD8<sup>+</sup> and B lymphocytes CD...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>C57BL/6 mice received CFSE-labeled, OVA-specific OT-I T cells (10<sup>7</sup>) <i>i.v.</i> Two da...
<p><b>A and D.</b> OVA-specific CFSE labeled CD4<sup>+</sup> T-cells were transferred to BALB/c reci...
<p>(A–C) Mice were primed with Env-CN54 gp140 in combination with either alum alone or a medium (“me...
<div><p>The need for CD4+ T cell responses to arise <i>de novo</i> following vaccination can limit t...
<p>Lymphocytes from the spleens of naïve, Liporale™-BCG vaccinated (BCG oral) or subcutaneously vacc...
<p>Mice were injected with various immunogens as shown on the x-axis; saline (○), unencapsulated OVA...
BACKGROUND: Modifications of adjuvants that induce cell-mediated over antibody-mediated immunity is ...
BackgroundModifications of adjuvants that induce cell-mediated over antibody-mediated immunity is de...
<div><h3>Background</h3><p>Modifications of adjuvants that induce cell-mediated over antibody-mediat...
Modifications of adjuvants that induce cell-mediated over antibody-mediated immunity is desired for ...
<p>T cells (2×10<sup>5</sup> cells/mL) were co-cultured with DC (2×10<sup>4</sup> cells/mL) in the p...
<p>Antibody titers after vaccination schedule, composed of 3 weekly s.c. injections with control sal...
<p>B3Z cells (1×10<sup>5</sup> cells/200 uL/well) were co cultured with DC 2.4 (5×10<sup>4</sup> cel...
<p>(<b>A</b>) Relative representation of Th CD4<sup>+</sup>, Tc CD8<sup>+</sup> and B lymphocytes CD...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>C57BL/6 mice received CFSE-labeled, OVA-specific OT-I T cells (10<sup>7</sup>) <i>i.v.</i> Two da...
<p><b>A and D.</b> OVA-specific CFSE labeled CD4<sup>+</sup> T-cells were transferred to BALB/c reci...
<p>(A–C) Mice were primed with Env-CN54 gp140 in combination with either alum alone or a medium (“me...
<div><p>The need for CD4+ T cell responses to arise <i>de novo</i> following vaccination can limit t...
<p>Lymphocytes from the spleens of naïve, Liporale™-BCG vaccinated (BCG oral) or subcutaneously vacc...